about
Keratinocyte growth factor gene therapy ameliorates ulcerative colitis in rats.C-reactive protein level at 2 weeks following initiation of infliximab induction therapy predicts outcomes in patients with ulcerative colitis: a 3 year follow-up studyT0001, a variant of TNFR2-Fc fusion protein, exhibits improved Fc effector functions through increased binding to membrane-bound TNFαPost-Transcriptional Regulation of Hepatic DDAH1 with TNF Blockade Leads to Improved eNOS Function and Reduced Portal Pressure In Cirrhotic Rats.Targeting IL-13 as a Host-Directed Therapy Against Ulcerative Colitis
P2860
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Infliximab in ulcerative colitis.
@en
type
label
Infliximab in ulcerative colitis.
@en
prefLabel
Infliximab in ulcerative colitis.
@en
P2860
P356
P1476
Infliximab in ulcerative colitis
@en
P2093
Oren Shibolet
P2860
P304
P356
10.2147/BTT.S2249
P577
2008-09-01T00:00:00Z